Suppr超能文献

确定血浆蛋白变异参数作为生物标志物研究的前提条件——基于TMT的液相色谱-串联质谱蛋白质组研究

Determining Plasma Protein Variation Parameters as a Prerequisite for Biomarker Studies-A TMT-Based LC-MSMS Proteome Investigation.

作者信息

Andersen Lou-Ann C, Palstrøm Nicolai Bjødstrup, Diederichsen Axel, Lindholt Jes Sanddal, Rasmussen Lars Melholt, Beck Hans Christian

机构信息

Department of Ophthalmology, Lillebaelt Hospital, DK-7100 Vejle, Denmark.

Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, DK-5000 Odense, Denmark.

出版信息

Proteomes. 2021 Dec 1;9(4):47. doi: 10.3390/proteomes9040047.

Abstract

Specific plasma proteins serve as valuable markers for various diseases and are in many cases routinely measured in clinical laboratories by fully automated systems. For safe diagnostics and monitoring using these markers, it is important to ensure an analytical quality in line with clinical needs. For this purpose, information on the analytical and the biological variation of the measured plasma protein, also in the context of the discovery and validation of novel, disease protein biomarkers, is important, particularly in relation to for sample size calculations in clinical studies. Nevertheless, information on the biological variation of the majority of medium-to-high abundant plasma proteins is largely absent. In this study, we hypothesized that it is possible to generate data on inter-individual biological variation in combination with analytical variation of several hundred abundant plasma proteins, by applying LC-MS/MS in combination with relative quantification using isobaric tagging (10-plex TMT-labeling) to plasma samples. Using this analytical proteomic approach, we analyzed 42 plasma samples prepared in doublets, and estimated the technical, inter-individual biological, and total variation of 265 of the most abundant proteins present in human plasma thereby creating the prerequisites for power analysis and sample size determination in future clinical proteomics studies. Our results demonstrated that only five samples per group may provide sufficient statistical power for most of the analyzed proteins if relative changes in abundances >1.5-fold are expected. Seventeen of the measured proteins are present in the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Biological Variation Database, and demonstrated remarkably similar biological CV's to the corresponding CV's listed in the EFLM database suggesting that the generated proteomic determined variation knowledge is useful for large-scale determination of plasma protein variations.

摘要

特定的血浆蛋白可作为各种疾病的重要标志物,在许多情况下,临床实验室会使用全自动系统对其进行常规检测。为了利用这些标志物进行安全的诊断和监测,确保符合临床需求的分析质量至关重要。为此,了解所测血浆蛋白的分析变异和生物学变异信息,尤其是在新型疾病蛋白生物标志物的发现和验证背景下,对于临床研究中的样本量计算尤为重要。然而,关于大多数中高丰度血浆蛋白的生物学变异信息却大多缺失。在本研究中,我们假设通过将液相色谱 - 串联质谱(LC-MS/MS)与等压标记(10重TMT标记)的相对定量方法相结合应用于血浆样本,有可能生成数百种丰度较高的血浆蛋白的个体间生物学变异与分析变异相结合的数据。使用这种分析蛋白质组学方法,我们分析了42个以双份制备的血浆样本,并估计了人血浆中265种最丰富蛋白质的技术变异、个体间生物学变异和总变异,从而为未来临床蛋白质组学研究中的功效分析和样本量确定创造了前提条件。我们的结果表明,如果预期丰度相对变化>1.5倍,每组仅五个样本可能就可为大多数分析的蛋白质提供足够的统计功效。所测的17种蛋白质存在于欧洲临床化学和检验医学联合会(EFLM)生物学变异数据库中,并且其生物学变异系数(CV)与EFLM数据库中列出的相应CV非常相似,这表明所生成的蛋白质组学确定的变异知识可用于大规模测定血浆蛋白变异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a9a/8707687/bea808a139ab/proteomes-09-00047-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验